203 related articles for article (PubMed ID: 25871640)
1. Serum 25-hydroxyvitamin D levels and prognosis in hematological malignancies: a systematic review and meta-analysis.
Wang W; Li G; He X; Gao J; Wang R; Wang Y; Zhao W
Cell Physiol Biochem; 2015; 35(5):1999-2005. PubMed ID: 25871640
[TBL] [Abstract][Full Text] [Related]
2. Serum 25-hydroxyvitamin D levels are associated with prognosis in hematological malignancies.
Thomas X; Chelghoum Y; Fanari N; Cannas G
Hematology; 2011 Sep; 16(5):278-83. PubMed ID: 21902891
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of the prognostic and clinical value of serum 25-hydroxyvitamin D levels in previously untreated lymphoma.
Tao Y; Chen H; Zhou Y; Shi Y
Future Oncol; 2021 May; 17(14):1825-1838. PubMed ID: 33728948
[TBL] [Abstract][Full Text] [Related]
4. Association of Circulating 25-Hydroxyvitamin D Levels with Colorectal Cancer: An Updated Meta-Analysis.
Xu J; Yuan X; Tao J; Yu N; Wu R; Zhang Y
J Nutr Sci Vitaminol (Tokyo); 2018; 64(6):432-444. PubMed ID: 30606966
[TBL] [Abstract][Full Text] [Related]
5. Impact of vitamin D level at diagnosis and transplantation on the prognosis of hematological malignancy: a meta-analysis.
Ito Y; Honda A; Kurokawa M
Blood Adv; 2022 Mar; 6(5):1499-1511. PubMed ID: 34496015
[TBL] [Abstract][Full Text] [Related]
6. Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis.
Li M; Chen P; Li J; Chu R; Xie D; Wang H
J Clin Endocrinol Metab; 2014 Jul; 99(7):2327-36. PubMed ID: 24780061
[TBL] [Abstract][Full Text] [Related]
7. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies.
Maalmi H; Ordóñez-Mena JM; Schöttker B; Brenner H
Eur J Cancer; 2014 May; 50(8):1510-21. PubMed ID: 24582912
[TBL] [Abstract][Full Text] [Related]
8. Association between Blood 25-Hydroxyvitamin D Levels and Survival in Colorectal Cancer Patients: An Updated Systematic Review and Meta-Analysis.
Maalmi H; Walter V; Jansen L; Boakye D; Schöttker B; Hoffmeister M; Brenner H
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30011816
[TBL] [Abstract][Full Text] [Related]
9. Circulating 25-hydroxyvitamin D level and prognosis of lung cancer patients: A systematic review and meta-analysis.
Huang JD; Dong CH; Shao SW; Gu TJ; Hu ZL; Ying J; Zhou DF; Xie YP
Bull Cancer; 2017; 104(7-8):675-682. PubMed ID: 28587766
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of circulating vitamin D binding protein, total, free and bioavailable 25-hydroxy vitamin D in patients with colorectal cancer.
Yang L; Chen H; Zhao M; Peng P
Oncotarget; 2017 Jun; 8(25):40214-40221. PubMed ID: 28388568
[TBL] [Abstract][Full Text] [Related]
11. Plasma 25-hydroxyvitamin D deficiency in the peri-operative period is associated with survival outcome in colorectal cancer patients: a meta-analysis.
Zheng B; Chen J; Gong X
BMC Surg; 2024 Jun; 24(1):180. PubMed ID: 38867218
[TBL] [Abstract][Full Text] [Related]
12. 25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival.
Kanstrup C; Teilum D; Rejnmark L; Bigaard JV; Eiken P; Kroman N; Tjønneland A; Mejdahl MK
Breast Cancer Res Treat; 2020 Feb; 179(3):699-708. PubMed ID: 31707511
[TBL] [Abstract][Full Text] [Related]
13. Low circulating 25-hydroxyvitamin D level is associated with increased colorectal cancer mortality: a systematic review and dose-response meta-analysis.
Wu G; Xue M; Zhao Y; Han Y; Zhang S; Zhang J; Li C; Xu J
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32686830
[TBL] [Abstract][Full Text] [Related]
14. Association of 25-hydroxyvitamin D level with survival outcomes in female breast cancer patients: A meta-analysis.
Li C; Li H; Zhong H; Li X
J Steroid Biochem Mol Biol; 2021 Sep; 212():105947. PubMed ID: 34214604
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of RDW in hematological malignancies: a systematic review and meta-analysis.
Ai L; Mu S; Hu Y
Cancer Cell Int; 2018; 18():61. PubMed ID: 29713244
[TBL] [Abstract][Full Text] [Related]
16. Serum Levels of 25-Hydroxyvitamin D at Diagnosis Are Not Associated with Overall Survival in Esophageal Adenocarcinoma.
Loehrer E; Betensky RA; Giovannucci E; Su L; Shafer A; Hollis BW; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1379-1387. PubMed ID: 31186263
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D deficiency is associated with the severity of COPD: a systematic review and meta-analysis.
Zhu B; Zhu B; Xiao C; Zheng Z
Int J Chron Obstruct Pulmon Dis; 2015; 10():1907-16. PubMed ID: 26392765
[TBL] [Abstract][Full Text] [Related]
18. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients.
Zhou W; Heist RS; Liu G; Asomaning K; Neuberg DS; Hollis BW; Wain JC; Lynch TJ; Giovannucci E; Su L; Christiani DC
J Clin Oncol; 2007 Feb; 25(5):479-85. PubMed ID: 17290055
[TBL] [Abstract][Full Text] [Related]
19. Integrated Analysis Reveals That Long Non-Coding RNA TUBA4B Can Be Used as a Prognostic Biomarker in Various Cancers.
Zhang T; Wu DM; Deng SH; Han R; Liu T; Li J; Xu Y
Cell Physiol Biochem; 2018; 49(2):530-544. PubMed ID: 30157490
[TBL] [Abstract][Full Text] [Related]
20. 25-hydroxyvitamin D concentration is positively associated with overall survival in advanced pancreatic cancer: A systematic review and meta-analysis.
Li J; Zhang H; Zhu H; Dai Z
Nutr Res; 2023 Sep; 117():73-82. PubMed ID: 37515942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
